3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
9
Esophageal Squamous Cell Carcinoma
5
Neoplasm Metastasis
4
Carcinoma, Hepatocellular
4
Advanced Solid Tumors
4
Recurrence
3
Colorectal Neoplasms
3
Stomach Neoplasms
2
Small Cell Lung Carcinoma
2
Neoplasms
2
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma
2
Uterine Cervical Neoplasms
1
Triple Negative Breast Neoplasms
1
Thyroid Carcinoma, Anaplastic
1
Solid Tumors
1
Sarcoma
1
Neuroendocrine Tumors
1
Nasopharyngeal Neoplasms
1
Melanoma
1
Lymphoma, T-Cell, Peripheral
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, T-Cell
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large-Cell, Anaplastic
1
Lymphoma, Follicular
1
Lymphoma, Extranodal NK-T-Cell
1
Lymphoma, B-Cell, Marginal Zone
1
Lung Neoplasms
1
Locally Advanced or Metastatic Urothelial Bladder Cancer
1
Interventions
Radiotherapy
22
Fluorouracil
20
Oxaliplatin
19
Leucovorin
14
Cisplatin
14
Paclitaxel
10
Radiation
8
Irinotecan
8
Docetaxel
7
Capecitabine
7
Cetuximab
6
Carboplatin
6
pembrolizumab
5
Neoadjuvant Therapy
5
Trastuzumab
4
Taxes
4
Chemotherapy, Adjuvant
4
Panitumumab
3
Microarray Analysis
3
Immunohistochemistry
3
Folfox protocol
3
Epirubicin
3
Biopsy
3
tucatinib
2
Surgical Procedures, Operative
2
Reverse Transcriptase Polymerase Chain Reaction
2
Magnetic Resonance Spectroscopy
2
Gene Expression Profiling
2
Gefitinib
2
Everolimus
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Adenocarcinoma Of Esophagus
×
tislelizumab
×
Clear all
No trials found.